NO922573L - Fremgangsmaate for aa paavise ben- og andre bindevevsforstyrrelser hos mennesker og dyr - Google Patents

Fremgangsmaate for aa paavise ben- og andre bindevevsforstyrrelser hos mennesker og dyr

Info

Publication number
NO922573L
NO922573L NO92922573A NO922573A NO922573L NO 922573 L NO922573 L NO 922573L NO 92922573 A NO92922573 A NO 92922573A NO 922573 A NO922573 A NO 922573A NO 922573 L NO922573 L NO 922573L
Authority
NO
Norway
Prior art keywords
bone
bonus
painting
animals
biological fluids
Prior art date
Application number
NO92922573A
Other languages
English (en)
Other versions
NO922573D0 (no
NO304760B1 (no
Inventor
Simon Peter Robins
Original Assignee
Rowett Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rowett Research Inst filed Critical Rowett Research Inst
Publication of NO922573D0 publication Critical patent/NO922573D0/no
Publication of NO922573L publication Critical patent/NO922573L/no
Publication of NO304760B1 publication Critical patent/NO304760B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/108—Osteoporosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
NO922084A 1989-12-30 1992-06-29 Fremgangsmaate for aa paavise ben- og andre bindevevsforstyrrelser hos mennesk og dyr et immunanalyse sett for bruk i fremgangsmaten og et monoklonalt antistoff NO304760B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898929366A GB8929366D0 (en) 1989-12-30 1989-12-30 Method to detect connective tissue disorder in humans and animals
PCT/GB1990/002030 WO1991010141A1 (en) 1989-12-30 1990-12-28 Method to detect bone and other connective tissue disorders in humans and animals

Publications (3)

Publication Number Publication Date
NO922573D0 NO922573D0 (no) 1992-06-29
NO922573L true NO922573L (no) 1992-06-29
NO304760B1 NO304760B1 (no) 1999-02-08

Family

ID=10668604

Family Applications (1)

Application Number Title Priority Date Filing Date
NO922084A NO304760B1 (no) 1989-12-30 1992-06-29 Fremgangsmaate for aa paavise ben- og andre bindevevsforstyrrelser hos mennesk og dyr et immunanalyse sett for bruk i fremgangsmaten og et monoklonalt antistoff

Country Status (17)

Country Link
US (2) US5700693A (no)
EP (2) EP0618448B1 (no)
JP (3) JPH087212B2 (no)
KR (1) KR0138503B1 (no)
AT (2) ATE122467T1 (no)
AU (2) AU648774B2 (no)
BR (1) BR9007969A (no)
CA (2) CA2069611C (no)
DE (2) DE69019375T2 (no)
DK (1) DK0507831T3 (no)
ES (2) ES2071979T3 (no)
FI (1) FI923028A0 (no)
GB (1) GB8929366D0 (no)
GR (1) GR3016998T3 (no)
HU (1) HUT64421A (no)
NO (1) NO304760B1 (no)
WO (1) WO1991010141A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6121002A (en) * 1990-12-26 2000-09-19 The Rowett Research Institute Method to detect bone and other connective tissue disorders in humans and animals
GB9202139D0 (en) * 1992-01-31 1992-03-18 Sandoz Ltd Improvements in or relating to organic compounds
DE69321503T2 (de) * 1992-03-19 1999-05-06 Hoechst Marion Roussel Ltd Gewebeantigen und seine Anwendung in einem Nachweisverfahren von humaner Osteoporose
US5620861A (en) * 1992-07-31 1997-04-15 Metra Biosystems, Inc. Method and kit for pyridinium crosslink assay
US5527715A (en) * 1992-07-31 1996-06-18 Metra Biosystems, Inc. Method and kit for pyridinoline assay
AU2481992A (en) * 1992-08-28 1994-03-29 Rowett Research Institute, The Method to monitor drug therapy and assess metastasis
US5736344A (en) * 1992-12-17 1998-04-07 Metra Biosystems, Inc. Serum pyridinium crosslinks assay
US5756361A (en) * 1992-12-17 1998-05-26 Metra Biosystems, Inc. Screening method for periodontal disease
JPH0792165A (ja) * 1993-09-21 1995-04-07 Hoechst Japan Ltd 骨粗鬆症診断剤
US5661039A (en) * 1995-03-01 1997-08-26 Metra Biosystems, Inc. Perspiration assay for bone resorption
US5972623A (en) * 1997-07-31 1999-10-26 Metra Biosystems, Inc. Collagen-peptide assay method
US6033918A (en) * 1997-11-10 2000-03-07 Bayer Corporation Method and device for the detection of analyte in a fluid sample
AU3035699A (en) * 1998-03-27 1999-10-18 Seibel, Markus Determination of the probability of bone metastases in patients with primary carcinomas
US6197592B1 (en) * 1999-07-15 2001-03-06 Bio-Rad Laboratories, Inc. Clinical control materials for detection of bone resorptive markers
AU9396401A (en) 2000-10-03 2002-04-15 Rowett Res Inst Method of assaying pyrrole-containing biological compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973666A (en) * 1987-11-06 1990-11-27 Washington Research Foundation Peptide fragments containing HP and LP cross-links
US5300434A (en) * 1987-11-06 1994-04-05 Washington Research Foundation Hybridoma cell line producing an antibody to type-I collagen amino-terminal telopeptide
GB8815174D0 (en) * 1988-06-25 1988-08-03 Rowett Research Inst Method of monitoring collagen degradation
US5283197A (en) * 1988-06-25 1994-02-01 The Rowett Research Institute Method of monitoring collagen degradation
GB8927377D0 (en) * 1989-12-04 1990-01-31 Univ Edinburgh Improvements in and relating to amperometric assays
US5620861A (en) * 1992-07-31 1997-04-15 Metra Biosystems, Inc. Method and kit for pyridinium crosslink assay
FI106326B (fi) * 1996-09-23 2001-01-15 Tellabs Oy Kytkentä kaiunpoistavan moninopeusmodeemin sovittamiseksi linjalle sekä kytkentämenetelmä

Also Published As

Publication number Publication date
US5700693A (en) 1997-12-23
AU682188B2 (en) 1997-09-25
DK0507831T3 (da) 1995-10-09
GB8929366D0 (en) 1990-02-28
JP3224356B2 (ja) 2001-10-29
CA2271544A1 (en) 1991-07-01
NO922573D0 (no) 1992-06-29
JPH05502942A (ja) 1993-05-20
US5700694A (en) 1997-12-23
JP2001050958A (ja) 2001-02-23
CA2069611A1 (en) 1991-07-01
EP0507831B1 (en) 1995-05-10
ES2147761T3 (es) 2000-10-01
ATE122467T1 (de) 1995-05-15
NO304760B1 (no) 1999-02-08
KR0138503B1 (en) 1998-05-15
EP0618448A1 (en) 1994-10-05
WO1991010141A1 (en) 1991-07-11
ES2071979T3 (es) 1995-07-01
DE69033511D1 (de) 2000-05-25
FI923028A (fi) 1992-06-30
FI923028A0 (fi) 1992-06-30
AU6864894A (en) 1994-11-24
ATE191976T1 (de) 2000-05-15
CA2271544C (en) 2006-01-17
GR3016998T3 (en) 1995-11-30
AU648774B2 (en) 1994-05-05
HUT64421A (en) 1993-12-28
JPH1045800A (ja) 1998-02-17
JPH087212B2 (ja) 1996-01-29
HU9202178D0 (en) 1992-10-28
EP0618448B1 (en) 2000-04-19
DE69019375T2 (de) 1995-09-14
DE69019375D1 (de) 1995-06-14
AU7065991A (en) 1991-07-24
BR9007969A (pt) 1993-02-02
CA2069611C (en) 1999-08-10
DE69033511T2 (de) 2000-11-16
EP0507831A1 (en) 1992-10-14

Similar Documents

Publication Publication Date Title
NO922573L (no) Fremgangsmaate for aa paavise ben- og andre bindevevsforstyrrelser hos mennesker og dyr
ES2071778T3 (es) Equivalentes de tejidos vivos.
DE69029257T2 (de) Anordnung zur bestrahlung von laserstrahlen
IS7770A (is) Hlutleysandi mótefni gegn GDF-8 og notkun theirra
DE69019726D1 (de) Vorrichtung zur bestrahlung mit einem laserstrahl.
WO2003087767A3 (en) A system and method for quantifying the dynamic response of a target system
DE69821246D1 (de) Testverfahren für collagenpeptid
DE69230000D1 (de) Verfahren und testsatz zur messung von endogenen zytokinen
ES2175453T3 (es) Procedimiento de diagnostico para la alterosclerosis.
Degueurce et al. Variability of the limb joint patterns of sound horses at trot
DK0764273T3 (da) Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose
ATE329638T1 (de) Vorrichtung, um in einem zielgebiet eines menschlichen oder tierischen körpers einen künstlichen isolierten kreislauf zu etablieren
DE68920477T2 (de) Verfahren zur Diagnose von Tumoren.
NO173336C (no) Fremgangsm}te til isolering av basalmembranproteiner fra human- eller animalvev og anvendelse av det oppn}dde protein
Hanhan et al. Regeneration of grade 3 ankle sprain, using the recombinant human amelogenin protein (rHAM+) in a rat model
ES2099876T3 (es) Procedimiento para la determinacion de anticuerpos de lupus anticoagulante que provocan trombosis.
Griffin Effect of mobilization on the biomechanical performance of juvenile avian gastrocnemius tendon
RU2000105525A (ru) Способ оценки степени тяжести интоксикации у детей с гнойно-септическими заболеваниями
ES2067216T3 (es) Glutamato como factor determinante del crecimiento.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees